1. Home
  2. ROAD vs RYTM Comparison

ROAD vs RYTM Comparison

Compare ROAD & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Construction Partners Inc.

ROAD

Construction Partners Inc.

HOLD

Current Price

$118.35

Market Cap

7.6B

Sector

Industrials

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$93.50

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROAD
RYTM
Founded
2001
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.4B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
ROAD
RYTM
Price
$118.35
$93.50
Analyst Decision
Buy
Strong Buy
Analyst Count
5
14
Target Price
$124.20
$129.43
AVG Volume (30 Days)
631.6K
748.9K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
40.46
28.34
EPS
0.31
N/A
Revenue
$785,679,000.00
N/A
Revenue This Year
$27.62
$58.38
Revenue Next Year
$9.86
$83.95
P/E Ratio
$404.48
N/A
Revenue Growth
0.31
N/A
52 Week Low
$64.79
$45.91
52 Week High
$141.90
$122.20

Technical Indicators

Market Signals
Indicator
ROAD
RYTM
Relative Strength Index (RSI) 38.96 42.10
Support Level $109.61 $83.98
Resistance Level $123.52 $96.92
Average True Range (ATR) 6.18 5.13
MACD -1.95 -0.58
Stochastic Oscillator 3.14 36.45

Price Performance

Historical Comparison
ROAD
RYTM

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: